Exclusive Webinar :Don't miss the latest webinar on Global Investing with Passive Products on June 22, 11am

Hope to launch 12-15 new products in next one year: Strides Shasun

An IIFL report quotes the management of Strides Shasun as saying that pharmaceutical benefits scheme price cuts have bottomed out. In an interview to CNBC-TV18, Shashank Sinha, MD of the company spoke about the same and gave his outlook for the future.

February 23, 2018 / 02:48 PM IST

An IIFL report quotes the management of Strides Shasun as saying that pharmaceutical benefits scheme price cuts have bottomed out. In an interview to CNBC-TV18, Shashank Sinha, MD of the company spoke about the same and gave his outlook for the future.

Sinha said that we are hoping to launch 12-15 new products in next one year.

He further said that under the new Generic Drug User Fee Amendments (GDUFA) regime, abbreviated new drug applications (ANDAs) are approved within a year.

Talking about business, he said we have been investing heavily in the business, especially research and development (R&D).

We are targeting 30-35 product launches on an annual basis in Australia, he added.

Close
For entire interview, watch accompanying video.
CNBC-TV18
TAGS: #Business
first published: Feb 23, 2018 02:46 pm
Sections